SANTHERA PHARM.HD.SF 0,10/ CH1276028821 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 108.79 mill.EUR | - | - |
Assets
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .5000 | 2.2000 | 2.3000 | 5.6000 | 1.9000 | ||||||
| Intangible Assets | 26.5000 | 23.6000 | 61.5000 | 58.5000 | 67.7000 | ||||||
| Long-Term Investments | .3000 | .7000 | .7000 | .7000 | .6000 | ||||||
| Fixed Assets | 28.4000 | 32.2000 | 67.2000 | 65.8000 | 71 | ||||||
| Inventories | 7.7000 | 10.1000 | 9.3000 | 6.9000 | .5000 | ||||||
| Accounts Receivable | 4.3000 | 5.4000 | 7.9000 | 8.9000 | 4.5000 | ||||||
| Cash and Cash Equivalents | 49.8000 | 45.2000 | 22 | 31.4000 | 12.4000 | ||||||
| Current Assets | 62.4000 | 77.6000 | 43.1000 | 49.3000 | 17.7000 | ||||||
| Total Assets | 90.8000 | 109.8000 | 110.3000 | 115.1000 | 88.7000 | ||||||
Liabilities
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.5000 | 4.7000 | 8.3000 | 9.5000 | 5.7000 | ||||||
| Long-term debt | - | 53.1000 | 54.6000 | 56.2000 | 57.9000 | ||||||
| Liabilities to Banks | 0.0000 | 53.1000 | 54.6000 | 56.2000 | 68.6000 | ||||||
| Provisions | 5.8000 | 8.5000 | 11.4000 | 11.4000 | 8.6000 | ||||||
| Liabilities | 16.4000 | 77.5000 | 82.5000 | 93.8000 | 95 | ||||||
| Share Capital | 6.3000 | 6.3000 | 10.7000 | 11.1650 | 19.4300 | ||||||
| Total Equity | 74.4000 | 32.3000 | 27.8000 | 21.2000 | -6.4000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 90.8000 | 109.8000 | 110.3000 | 115.1000 | 88.7000 | ||||||
Income Statement
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 19 | 22.9000 | 31.7000 | 75.4000 | 15 | ||||||
| Depreciation (total) | .2000 | .3000 | .3000 | .3000 | - | ||||||
| Operating Result | -33.1000 | -50.5000 | -51.4000 | -10.4000 | -53.1000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -33.2000 | -51.3000 | -53.9000 | -18.4000 | -67.5000 | ||||||
| Income Taxes | -2.2000 | -.2000 | -.3000 | -.6000 | -.2000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -35.4000 | -51.5000 | -54.2000 | -19 | -67.7000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -27.1000 | -39.6000 | -37.9000 | 2.6000 | -43.5000 | ||||||
| Cash Flow from Investing Activities | -.5000 | -22.2000 | -5.9000 | 2.8000 | 1.6000 | ||||||
| Cash Flow from Financing | .6000 | 57.1000 | 20.6000 | 4.1000 | 23.2000 | ||||||
| Decrease / Increase in Cash | -27 | -4.6000 | -23.2000 | 9.4000 | -18.9000 | ||||||
| Employees | 80 | 112 | 119 | 117 | 91 | ||||||
